Content

Events
About

Combating Resistance in Antibiotic Drug Discovery and Development

Pharma IQ | 11/01/2010
The epidemiology of increasing resistance problem continues to garner much attention. A bacteria capable of opposing the inhibitory (bacteriostatic) or killing (bacteriocidal) effects of antibiotics has unfortunately become an increasingly common occurrence and presents a serious threat to successful treatment of bacterial infections. In this interview Dr. Mark Brian Anderson, Chief Scientific Officer at NovaBay Pharmaceuticals, speaks to Andrea Charles from Pharma IQ, about the growing market... To continue reading this story Click Here

Upcoming Events


SmartLab Exchange Europe

February 25 - 26, 2025
Novotel Amsterdam City, Netherlands
Register Now | View Agenda | Learn More


SmartLab Exchange USA 2025

08 - 09 April, 2025
Le Méridien, Fort Lauderdale, Florida, USA
Register Now | View Agenda | Learn More

MORE EVENTS